CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 140 enrolled
Drug / intervention
Restylane Lyft Lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05622812
NCT05622812N/ACompleted

A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multicenter Study to Evaluate Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

Galderma R&D·interventional·Posted Nov 21, 2022·Updated Mar 7, 2025

In Brief

A clinical study evaluating Restylane Lyft Lidocaine for Jawline Definition. Completed, enrolled 140 participants across 9 sites.

Detailed Summary

This study is designed to evaluate effectiveness and safety of Restylane Lyft Lidocaine for Jawline definition

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 21, 2022
Enrollment StartFeb 16, 2023
Primary CompletionOct 16, 2023
Study CompletionJun 14, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.6 years ago

Interventions

Restylane Lyft Lidocainedevice

Treatment for Jawline definition